CSIMarket
 


Protalix Biotherapeutics inc   (PLX)
Other Ticker:  
 
 

Protalix Biotherapeutics Inc Accounts Receivables Turnover Ratio from the second quarter 2024 to the second quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Protalix Biotherapeutics Inc 's ability to collect accounts receivable sequentially worsen to 5.42, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Protalix Biotherapeutics Inc 's Average receivable collection period in the Jun 30 2024 quarter, has increased to 67 days, from 34 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 268 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 870 to 2023.

What is Receivable Turnover Ratio?
What is Protalix Biotherapeutics Inc Selling?


What is Receivable Turnover Ratio?




PLX Receivables Turnover Ratio (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Receivable Change 150.09 % 188.27 % 14.96 % 3.28 % 100.25 %
Y / Y Revenue Change -61.59 % -60.91 % 21.69 % -27.06 % 300.72 %
Receivable Turnover Ratio (TTM) 5.42 10.84 13.39 13.48 14.52
PLX's Total Ranking # 2023 # 870 # 588 # 883 # 855
Average receivable collection period 67 34 27 27 25
Seq. Receivable Change 169.38 % -28.7 % -41 % 120.67 % 210.51 %
Seq. Revenue Change 259.5 % -64.26 % 1.36 % -70.51 % 265.82 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 25
Healthcare Sector # 269
Overall Market # 2023

Receivable Turnover Ratio Statistics
High Average Low
15.91 6.36 -2.83
(Jun 30 2021)   (Sep 30 2016)






Financial Statements
Protalix Biotherapeutics Inc 's Accounts Receivable $ 10 Millions Visit PLX's Balance sheet
Protalix Biotherapeutics Inc 's Sales TTM $ 38 Millions Visit PLX's Income Statement
Sources of PLX's Revenues Visit PLX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PLX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PLX's Growth Rates PLX's Roa PLX's Inventory Turnover Ratio PLX's Dividend Comparisons
PLX's Profitability Ratios PLX's Roi PLX's Asset Turnover Ratio PLX's Dividend Growth
PLX's Valuation Ratios PLX's Roe PLX's Financial Strength Ratios PLX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Receivable at quarter ending Jun 30 2024
Procyon Corporation  10.28 $ 4.984  Millions$ 0.485  Millions
Option Care Health Inc   10.18 $ 4,589.168  Millions$ 450.641  Millions
Tonix Pharmaceuticals Holding Corp   10.17 $ 12.458  Millions$ 1.225  Millions
Immucell Corp   10.00 $ 19.837  Millions$ 1.984  Millions
Addus Homecare Corporation  9.88 $ 1,112.632  Millions$ 112.633  Millions
Rockwell Medical inc   9.68 $ 88.849  Millions$ 9.177  Millions
Clearpoint Neuro Inc   9.66 $ 28.069  Millions$ 2.905  Millions
Quidelortho Corp  9.64 $ 2,834.600  Millions$ 293.925  Millions
Dianthus Therapeutics Inc   9.59 $ 5.563  Millions$ 0.580  Millions
Bluebird Bio Inc   9.55 $ 54.900  Millions$ 5.750  Millions
Adma Biologics Inc   9.50 $ 328.899  Millions$ 34.618  Millions
Lensar Inc   9.49 $ 45.124  Millions$ 4.755  Millions
Longeveron Inc   9.41 $ 1.383  Millions$ 0.147  Millions
Fate Therapeutics Inc   9.35 $ 12.317  Millions$ 1.318  Millions
Capricor Therapeutics inc   9.32 $ 27.152  Millions$ 2.915  Millions
Viemed Healthcare Inc   9.31 $ 205.699  Millions$ 22.091  Millions
Myomo Inc   9.26 $ 21.079  Millions$ 2.277  Millions
Equillium Inc   9.24 $ 42.623  Millions$ 4.611  Millions
United Therapeutics Corporation  9.22 $ 2,616.700  Millions$ 283.875  Millions
Femasys Inc   9.15 $ 0.950  Millions$ 0.104  Millions
The Pennant Group Inc   9.13 $ 611.806  Millions$ 66.978  Millions
Astrotech Corp  9.13 $ 2.043  Millions$ 0.224  Millions
Cidara Therapeutics Inc   9.06 $ 65.056  Millions$ 7.183  Millions
Inspire Medical Systems inc   8.98 $ 703.529  Millions$ 78.348  Millions
Generation Bio Co   8.85 $ 13.174  Millions$ 1.489  Millions
Veracyte Inc   8.83 $ 390.064  Millions$ 44.161  Millions
Enanta Pharmaceuticals Inc  8.80 $ 71.960  Millions$ 8.180  Millions
Acadia Pharmaceuticals Inc   8.74 $ 890.534  Millions$ 101.839  Millions
Alpha Pro Tech Ltd   8.71 $ 60.181  Millions$ 6.910  Millions
Scientific Industries Inc   8.69 $ 10.454  Millions$ 1.202  Millions

Date modified: 2024-09-06T06:01:08+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com